Agrani Insurance (DHA:AGRANINS) Research & Development: BDT Mil (TTM As of . 20)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

DHA:AGRANINS Agrani Insurance PLC DHA:AGRANINS
18 GF Score
Price BDT28.40
! 1 Warning Sign
View Full Analysis

What is Agrani Insurance Research & Development?

Agrani Insurance DHA:AGRANINS +0.35% 18 Research & Development is BDT Mil as of . 20. GuruFocus rates DHA:AGRANINS with a GF Score™ of 18/100. The stock has 1 warning sign investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Agrani Insurance's Research & Development for the six months ended in . 20 was BDT0.00 Mil. Agrani Insurance does not have enough years/quarters to calculate the Research & Development for the trailing twelve months (TTM) ended in . 20.

Agrani Insurance  (DHA:AGRANINS) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Agrani Insurance Research & Development Related Terms

Agrani Insurance Research & Development Historical Data

* Premium members only.

The historical data trend for Agrani Insurance's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Agrani Insurance Research & Development Chart

Agrani Insurance Annual Data
Trend
Research & Development

Agrani Insurance Semi-Annual Data
Research & Development
DHA:AGRANINS
18GF Score
Agrani Insurance PLC DHA:AGRANINS
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Agrani Insurance Research & Development Calculation

This is the expense the company spent on research and development.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of BDT Mil mean?
Agrani Insurance (DHA:AGRANINS) has a Research & Development of BDT Mil as of . 20. Research and development expense is the total cost for research and development activities. View historical data on Agrani Insurance and its competitors.
Is Agrani Insurance's Research & Development too high?
Agrani Insurance's current Research & Development is BDT Mil. Overall, Agrani Insurance has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Agrani Insurance's Research & Development compare to ASIN and AFH?
Agrani Insurance's Research & Development of BDT Mil can be compared against companies in the Insurance industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for an Insurance company?
A good Research & Development depends on the Insurance industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Agrani Insurance and its competitors. Agrani Insurance's current Research & Development is BDT Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Agrani Insurance stock overvalued right now?
Agrani Insurance (DHA:AGRANINS) has a current Research & Development of BDT Mil. The current Research & Development is BDT Mil. Agrani Insurance's overall GF Score™ is 18/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Agrani Insurance (DHA:AGRANINS), the current Research & Development is BDT Mil as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Agrani Insurance Business Description

Address City Centre, Level no. 17, 90/1, Motijheel C/A, Dhaka, BGD
Agrani Insurance PLC, formerly known as Agrani Insurance Co Ltd, is engaged in the non-life insurance business in Bangladesh. The company covers fire, health, motor, marine, burglary insurance, and others.
18GF Score

Get the complete analysis for DHA:AGRANINS

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

BDT28.40
Price